Mercado abrirá em 1 h 38 min

Hologic, Inc. (HOLX)

NasdaqGS - NasdaqGS Preço em Tempo Real. Moeda em USD.
Adicionar à lista
74,22-0,89 (-1,18%)
No fechamento: 04:00PM EST
74,22 0,00 (0,00%)
Pós-fechamento: 07:47PM EST

Hologic, Inc.

250 Campus Drive
Marlborough, MA 01752
United States
508 263 2900
https://www.hologic.com

Setor(es)Healthcare
IndústriaMedical Instruments & Supplies
Funcionários Integrais6.705

Principais Executivos

NomeTítuloPagarExercidoNascido em
Mr. Stephen P. MacMillanChairman, CEO & Pres4,51MN/A1964
Ms. Karleen M. ObertonChief Financial Officer1,6MN/A1971
Mr. John M. GriffinGen. Counsel1,56M1,73M1961
Mr. Kevin R. ThornalGroup Pres of Global Diagnostic Solutions1,66M595,56k1974
Mr. Paul MalenchiniChief Information OfficerN/AN/AN/A
Ryan M. SimonVP of Investor RelationsN/AN/AN/A
Ms. Elisabeth A. HellmannSr. VP of Global HR & Corp. CommunicationsN/AN/A1969
Mr. Jan VerstrekenGroup Pres of InternationalN/AN/A1968
Ms. Monica Aguirre BerthelotVP & Chief of StaffN/AN/AN/A
Mr. Mike KellyChief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory AffairsN/AN/AN/A
Os valores são a partir de 31 de dezembro de 2021, e os valores de compensação são relativos ao ano fiscal terminando naquela data. O pagamento é salário, bônus, etc. Exercido é o valor de opções exercidas durante o ano fiscal. Moeda em USD.

Descrição

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Governança Corporativa

O QualityScore de governança da ISS da Hologic, Inc. a partir de 1 de outubro de 2022 é 3. As principais pontuações para Auditoria são: 2; Conselho: 6; Direitos de Acionistas: 6; Compensação: 2.

Pontuações em governança corporativa são cortesia da Institutional Shareholder Services (ISS). As pontuações indicam a posição do decil em relação ao índice ou à região. Uma decil com pontuação 1 indica menor risco de governança, enquanto uma pontuação 10 indica um maior risco de governança.